UroFocus retweeted
Renal cancer highlights #ESMO26 1) Final OS data for LS11 (Lenvatinib/belzutifan vs cabo in pretreated disease) & final OS for KN564 (adjuvant pembro vs placebo) @DrChoueiri 2) 1st line triplet data for Len/pembo/bel vs Len/pembro/CTLA4 vs Len/pembro @brian_rini Press release shows it’s negative. Triplets appear hard in RCC. 3) New monotherapy data for Ivanesimab (VEGF/PD1) and more data. Combination trials to follow 4) A randomised phase II of metastasis-directed therapy +/- pembro @DrIacovelli Finally phase 2 data of ENPP3/CD3 T cell engager @montypal @myESMO @Annals_Oncology @OncoAlert
UroFocus retweeted
📢 New publication in European Urology!
We are pleased to highlight a new study published in European Urology, titled “Diagnostic Performance of Biparametric versus Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis: An Updated Systematic Review and Meta-analysis”.
👏 Congratulations to Strieder de Oliveira G., Stephan Altmayer, and Dias A.B. this excellent contribution, together with all co-authors.
🔗 Read the full article here:
👉 lnkd.in/guiTpuy4
#EuropeanUrology #Urology #UroOncology #Research #MedicalResearch #AcademicUrology
UroFocus retweeted
Another international 🇺🇸 🇨🇦 🇫🇷 🇯🇵 🇧🇪 🇮🇹 🇩🇪 🇳🇱 collaboration in @NatureMedicine with the Zitvogel/Routy/Derosa/Paragios et al finding that Histidine (+) vs Succinate (-) impact cancer immunotherapy. Histidine supplementation enhanced antitumor immunity in mice. Histidine-rich diets improved outcomes in patients lacking microbiome signatures of histidine catabolism. Bravo @ReneeSaliby @MarcMachaalani now @YaleIMed !
nature.com/articles/s41591-0…
UroFocus retweeted
Today is world #kidneycancer day! We have made lots of progress in all stages, but so much work still to do!
#kcsm @kidneycan @DanaFarber_GU
UroFocus retweeted
The 2nd UroOncoJourney in Rome 🇮🇹, was a great success! More than 140 participants, great speakers and a recognized place to discuss 1y of news in GU cancers! Special thank to @cvulsteke and to @cosimodenunzio @Albert0Briganti @BovePierluigi @GiuliaMarvaso84 @PasRescigno @alongi_filippo @SciarraUrology @AndreaTubaro @LuigiFormisano_ @ciccarese_c @GFornarini @RoccoPapaliaUro @MariaChiaraMCS @Sebastiano_Buti @giannatempopatr and many others. See you next year! @OncoAlert @oncodaily @OncoDailyGU @urofocus
UroFocus retweeted
Incredibly honored to be appointed Adjunct Professor at @OhioStateMed College of Medicine.
Thanks to @ChristianRolfo, the entire @OhioStateMedOnc team, my mentor Prof. Troncone, my group, and @UniNaofficial for the support.
@isliquidbiopsy @pmmpitalia
UroFocus retweeted
Many thanks to #ASCO, @nabiladra, @DrDarrenFeldman @siadaneshman for this excellent session: lively discussion, great energy, and many inspiring insights to bring home. #ASCO26 @oncodaily @Oncoinfo_it @TestesCancer
Lo studio Lirespark-022 ha confrontato Belzutifan+Pembro vs Placebo+Pembro in pts con RCC operato ad elevato rischio di recidiva. Ne abbiamo parlato con @fmassari79 .
Ascolta la puntata su open.spotify.com/episode/4LQ…
Poche neoplasie stanno subendo un mutamento come il k vescicale specie nella sua fase localizzata muscolo infiltrante.
Quale neoadiuvante? Serve ancora la cistectomia?
Ne parliamo con Dr Calabro'.👇
open.spotify.com/episode/6TD…
UroFocus retweeted
Discussion #EAU26 about the future of cystectomy neoadjuvant treatment and radiotherapy in muscle invasive bladder cancer. Things are changing rapidly. With pCR rates >50% for EVP many patients will want to keep their bladders. An era of ‘EVP 1st and ask questions later’ maybe a reality soon. Generation of EVP bladder sparing data is a priority. @Uroweb @EUplatinum
Sei curioso di sapere quali sono state le novità su #RCC presentate a #GU26? Non perdere la puntata e vai sul link qui sotto...
open.spotify.com/episode/3es…
Urofocus ti da appuntamento per ulteriori approfondimenti nelle prossime settimane.
Importanti novità nel trattamento del tumore vescicale nella giornata 2 di #GU26. Non perdere l'aggiornamento e i commenti del nostro team! Vai al link... open.spotify.com/episode/2AH…
UroFocus retweeted
🎙️ New episode of UroFocus is out.
We’re talking about burnout — honestly, openly, no filters.
🎧 Listen here:
open.spotify.com/episode/63n… @LuigiFormisano_ @DrIacovelli @AssPalinuro @Oncoinfo_it @oncodaily
UroFocus retweeted
> 🎙️ New episode of #UroFocus! Fresh highlights from #ESMO25 on bladder cancer 🧬🔍
Emerging data, evolving treatments, and what’s next in the field.
▶️ Listen here: open.spotify.com/episode/0nQ… @DrIacovelli @LuigiFormisano_ @urofocus @oncodaily @AssPalinuro @Oncoinfo_it
📢È stato un #ESMO25 entusiasmante per il #tumoredellavescica con 3️⃣ studi in sessione presidenziale ‼️
Non perderti l'aggiornamento di @urofocus e ascoltaci qui 👉🏻 open.spotify.com/episode/0nQ… @SIU_Italia @siuroIT @giannatempopatr @LuigiFormisano_ @DrIacovelli
UroFocus retweeted
#UroFocus is back with the hottest updates from #BladderDay #ESMO25!
💡 NMIBC: new approaches
🎯 mUC: strategic deintensification
🧬 Adjuvant therapy
Don’t miss it👉 spotify.link/XsPxbkeRyXb @oncodaily @Oncoinfo_it @myESMO @DrIacovelli @LuigiFormisano_ @fmassari79 @vmollica7
Sei curioso come noi di sapere cosa è successo nella giornata 1️⃣ di #ESMO25 ❓️Non perderti l'ultima puntata di @urofocus con degli ospiti d'eccezione! Vai a▶️ spotify.link/XsPxbkeRyXb Grazie a @fmassari79 @vmollica7 @Ric_Campi @siuroIT @SIU_Italia @AIOMtweet
UroFocus retweeted
Great start of #ESMO25 by @myESMO President and the Scientific co - chairs @DrChoueiri and @MyriamChalabi!!
A pawerful #vision on the future of Oncology as a multidisciplinary community!
UroFocus retweeted
POTOMAC trial introduces a new standard in #NMIBC showing significant EFS increase waiting for OS at #ESMO25. @myESMO @OncoAlert @GUOncologyNow @EAU_Uroonco
